Synergistic therapeutic effect of cisplatin and phosphatidylinositol 3-kinase (PI3K) inhibitors in cancer growth and metastasis of Brca1 mutant tumors.
about
WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistanceAmmonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatinThe role of cytoskeleton and adhesion proteins in the resistance to photodynamic therapy. Possible therapeutic interventions.Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancerPotential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype.NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin.Wee1 Inhibitor AZD1775 Combined with Cisplatin Potentiates Anticancer Activity against Gastric Cancer by Increasing DNA Damage and Cell Apoptosis.Synergistic Antitumor Effect of Oligogalacturonides and Cisplatin on Human Lung Cancer A549 Cells
P2860
Q36297939-27B1E96F-BEEF-4D7E-A23B-4C87432ECB5EQ37686235-86133FC7-4112-4824-A811-19C063EF147FQ38400490-84E62579-89EA-4122-834B-8AD2FD73A4EAQ41345175-58CDC79B-FE94-4E92-BD5A-C1256F3FDB9FQ42700663-D0484C74-959D-4493-99BE-5677D48F2260Q54979107-4429E52A-7533-4BF8-A617-CF10DE60F65CQ55445065-5676C00B-46E7-4B1A-AC0F-4046908C72EDQ58462039-5A49F7B7-1640-48AF-94F5-C07F56A2B7B6
P2860
Synergistic therapeutic effect of cisplatin and phosphatidylinositol 3-kinase (PI3K) inhibitors in cancer growth and metastasis of Brca1 mutant tumors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Synergistic therapeutic effect ...... stasis of Brca1 mutant tumors.
@ast
Synergistic therapeutic effect ...... stasis of Brca1 mutant tumors.
@en
Synergistic therapeutic effect of cisplatin and phosphatidylinositol 3-kinase
@nl
type
label
Synergistic therapeutic effect ...... stasis of Brca1 mutant tumors.
@ast
Synergistic therapeutic effect ...... stasis of Brca1 mutant tumors.
@en
Synergistic therapeutic effect of cisplatin and phosphatidylinositol 3-kinase
@nl
prefLabel
Synergistic therapeutic effect ...... stasis of Brca1 mutant tumors.
@ast
Synergistic therapeutic effect ...... stasis of Brca1 mutant tumors.
@en
Synergistic therapeutic effect of cisplatin and phosphatidylinositol 3-kinase
@nl
P2093
P2860
P356
P1476
Synergistic therapeutic effect ...... astasis of Brca1 mutant tumors
@en
P2093
Athanassios Vassilopoulos
Chu-Xia Deng
Cristine Chisholm
Cuiying Xiao
Tyler J Lahusen
Weiping Chen
Xiaoling Xu
P2860
P304
24202-24214
P356
10.1074/JBC.M114.567552
P407
P577
2014-07-08T00:00:00Z